The McKesson-backed healthcare analytics software provider boosted its valuation to $3.3bn in a series E round that came just two months after its series D.
Komodo Health, the US-based healthcare analysis software provider that counts medical products distributor McKesson as an investor, secured $220m in series E funding yesterday at a reported $3.3bn valuation.
Hedge fund manager Tiger Global Management led the round, which also featured Casdin Capital, Iconiq Growth, Andreessen Horowitz and SVB Capital.
Founded in 2014, Komodo is the creator of a software platform that tracks the progress of patients’ treatment, using artificial intelligence and data science to identify ways to make the…
